- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1866-1955
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeted treatments for fragile X syndrome ; volume:3 ; number:3 ; day:19 ; month:2 ; year:2011 ; pages:193-210 ; date:9.2011
Journal of neurodevelopmental disorders ; 3, Heft 3 (19.2.2011), 193-210, 9.2011
- Urheber
-
Berry-Kravis, Elizabeth
- Beteiligte Personen und Organisationen
-
Knox, Andrew
Hervey, Crystal
SpringerLink (Online service)
- DOI
-
10.1007/s11689-011-9074-7
- URN
-
urn:nbn:de:1111-2016021612520
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Berry-Kravis, Elizabeth
- Knox, Andrew
- Hervey, Crystal
- SpringerLink (Online service)
Ähnliche Objekte (12)
Systematic review of pharmacological treatments in fragile X syndrome
Phosphodiesterase 4-targeted treatments for autoimmune diseases
Modeling fragile X syndrome
Aging in fragile X syndrome
Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome
Developmental studies in fragile X syndrome
Looking forward to new targeted treatments for chronic spontaneous urticaria
Fragile X targeted pharmacotherapy: lessons learned and future directions
Advancing artificial intelligence-assisted pre-screening for fragile X syndrome
Treatments for irritable bowel syndrome: patients' attitudes and acceptability
Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome
Automatic vocalisation-based detection of fragile X syndrome and Rett syndrome
Systematic review of pharmacological treatments in fragile X syndrome
Phosphodiesterase 4-targeted treatments for autoimmune diseases
Modeling fragile X syndrome
Aging in fragile X syndrome
Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome
Developmental studies in fragile X syndrome
Looking forward to new targeted treatments for chronic spontaneous urticaria
Fragile X targeted pharmacotherapy: lessons learned and future directions
Advancing artificial intelligence-assisted pre-screening for fragile X syndrome
Treatments for irritable bowel syndrome: patients' attitudes and acceptability
Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome
Automatic vocalisation-based detection of fragile X syndrome and Rett syndrome
Systematic review of pharmacological treatments in fragile X syndrome
Phosphodiesterase 4-targeted treatments for autoimmune diseases
Modeling fragile X syndrome
Aging in fragile X syndrome
Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome
Developmental studies in fragile X syndrome
Looking forward to new targeted treatments for chronic spontaneous urticaria
Fragile X targeted pharmacotherapy: lessons learned and future directions
Advancing artificial intelligence-assisted pre-screening for fragile X syndrome
Treatments for irritable bowel syndrome: patients' attitudes and acceptability
Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome